Annual ROE
-82.11%
-35.00%-74.29%
December 31, 2023
Summary
- As of March 12, 2025, MTNB annual return on equity is -82.11%, with the most recent change of -35.00% (-74.29%) on December 31, 2023.
- During the last 3 years, MTNB annual ROE has fallen by -35.72% (-77.00%).
- MTNB annual ROE is now -131.62% below its all-time high of -35.45%, reached on December 31, 2013.
Performance
MTNB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-123.06%
-2.56%-2.12%
September 30, 2024
Summary
- As of March 12, 2025, MTNB quarterly return on equity is -123.06%, with the most recent change of -2.56% (-2.12%) on September 30, 2024.
- Over the past year, MTNB quarterly ROE has dropped by -52.34% (-74.01%).
- MTNB quarterly ROE is now -284.08% below its all-time high of -32.04%, reached on March 31, 2021.
Performance
MTNB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MTNB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.3% | -74.0% |
| 3 y3 years | -77.0% | -74.0% |
| 5 y5 years | +21.8% | -74.0% |
MTNB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -104.9% | at low | -221.3% | at low |
| 5 y | 5-year | -104.9% | at low | -284.1% | at low |
| alltime | all time | -131.6% | +82.1% | -284.1% | +42.7% |
Matinas BioPharma Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -123.06%(+2.1%) |
| Jun 2024 | - | -120.50%(+9.9%) |
| Mar 2024 | - | -109.67%(+22.9%) |
| Dec 2023 | -82.11%(+74.3%) | -89.20%(+26.1%) |
| Sep 2023 | - | -70.72%(+16.1%) |
| Jun 2023 | - | -60.91%(+17.7%) |
| Mar 2023 | - | -51.74%(+7.6%) |
| Dec 2022 | -47.11%(+17.6%) | -48.10%(-4.1%) |
| Sep 2022 | - | -50.15%(+4.2%) |
| Jun 2022 | - | -48.14%(+14.0%) |
| Mar 2022 | - | -42.21%(+10.2%) |
| Dec 2021 | -40.07%(-13.6%) | -38.30%(+6.8%) |
| Sep 2021 | - | -35.86%(+11.3%) |
| Jun 2021 | - | -32.22%(+0.6%) |
| Mar 2021 | - | -32.04%(-9.9%) |
| Dec 2020 | -46.39%(-34.3%) | -35.58%(-4.9%) |
| Sep 2020 | - | -37.42%(-5.0%) |
| Jun 2020 | - | -39.40%(-0.5%) |
| Mar 2020 | - | -39.58%(-22.3%) |
| Dec 2019 | -70.63% | -50.92%(-2.4%) |
| Sep 2019 | - | -52.17%(-8.5%) |
| Jun 2019 | - | -57.02%(-26.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -77.56%(-36.0%) |
| Dec 2018 | -105.00%(-39.5%) | -121.23%(-5.8%) |
| Sep 2018 | - | -128.68%(+5.5%) |
| Jun 2018 | - | -121.94%(+6.5%) |
| Mar 2018 | - | -114.45%(-4.4%) |
| Dec 2017 | -173.69%(+51.1%) | -119.71%(+9.2%) |
| Sep 2017 | - | -109.61%(-4.8%) |
| Jun 2017 | - | -115.17%(-1.9%) |
| Mar 2017 | - | -117.41%(-9.9%) |
| Dec 2016 | -114.94%(-47.8%) | -130.28%(-2.1%) |
| Sep 2016 | - | -133.11%(-4.2%) |
| Jun 2016 | - | -139.01%(+1.9%) |
| Mar 2016 | - | -136.48%(-9.5%) |
| Dec 2015 | -220.12%(-52.0%) | -150.83%(-10.3%) |
| Sep 2015 | - | -168.08%(-13.1%) |
| Jun 2015 | - | -193.33%(-10.0%) |
| Mar 2015 | - | -214.93%(+15.9%) |
| Dec 2014 | -458.77%(+1194.1%) | -185.49%(+56.4%) |
| Sep 2014 | - | -118.57%(+29.0%) |
| Jun 2014 | - | -91.88%(+52.8%) |
| Mar 2014 | - | -60.15%(+69.7%) |
| Dec 2013 | -35.45% | -35.45% |
FAQ
- What is Matinas BioPharma Holdings annual return on equity?
- What is the all time high annual ROE for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual ROE year-on-year change?
- What is Matinas BioPharma Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly ROE year-on-year change?
What is Matinas BioPharma Holdings annual return on equity?
The current annual ROE of MTNB is -82.11%
What is the all time high annual ROE for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual return on equity is -35.45%
What is Matinas BioPharma Holdings annual ROE year-on-year change?
Over the past year, MTNB annual return on equity has changed by -35.00% (-74.29%)
What is Matinas BioPharma Holdings quarterly return on equity?
The current quarterly ROE of MTNB is -123.06%
What is the all time high quarterly ROE for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly return on equity is -32.04%
What is Matinas BioPharma Holdings quarterly ROE year-on-year change?
Over the past year, MTNB quarterly return on equity has changed by -52.34% (-74.01%)